trientine has been researched along with malondialdehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, L; Cai, JH; Wang, CY; Wang, T; Wang, X; Wang, ZY; Xie, JW; Xu, Y; Zhao, BL | 1 |
| Chen, DX; Li, N; Sun, LB; Wang, XX; Yin, JM; Zheng, JS | 1 |
2 other study(ies) available for trientine and malondialdehyde
| Article | Year |
|---|---|
Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Amyloidosis; Animals; Aspartic Acid Endopeptidases; Cell Line, Tumor; Cerebral Cortex; Ceruloplasmin; Chelating Agents; Copper; Down-Regulation; Female; Glycation End Products, Advanced; Humans; Malondialdehyde; Mice; Mice, Inbred C57BL; Mice, Transgenic; NF-kappa B; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Signal Transduction; Superoxide Dismutase; Superoxide Dismutase-1; Trientine | 2013 |
Copper chelation by trientine dihydrochloride inhibits liver RFA-induced inflammatory responses in vivo.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Catheter Ablation; Chelating Agents; Copper; Cytokines; Liver; Male; Malondialdehyde; Rats, Sprague-Dawley; Superoxide Dismutase; Trientine | 2016 |